Valdecoxib | Interleukin Related interleukin-related.com

Product Name :
Valdecoxib

Search keywords :
Valdecoxib

drugId :
null

Target Vo:
Cyclooxygenase-2

Target Vo Short Name :
COX-2

Moa_Name:
Cyclooxygenase-2 inhibitors

First Approval Country :
United States

First Approval Date Filter:
2001

Origin Company_Name :
Pfizer Ag

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Osteoarthritis

Termination Status :

China Termination Status :

Highest Status:
Withdrawn

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
LGR5 Antibody (YA1842) Autophagy
Golimumab MedChemExpress
Dnmt3a Antibody: Dnmt3a Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 102 kDa, targeting to Dnmt3a. It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts